InterCure

InterCure Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of InterCure (INCR.TA) as of Oct 9, 2026 is 0.71. In the previous year, Net Debt to Free Cash Flow Ratio was -5.65 — a change of -112.57% (higher).

Net Debt/FCF

0.71

YoY

-112.57%

Last updated:

Net Debt to Free Cash Flow Ratio of InterCure is 2022 0.71 . Net Debt to Free Cash Flow Ratio of InterCure was 2021 -5.65 . It decreases by -112.57% higher compared to the previous year.

The InterCure Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2014
0.80 ILS
Jan 1, 2016
0.68 ILS
Jan 1, 2017
-0.54 ILS
Jan 1, 2018
-5.77 ILS
Jan 1, 2019
0.26 ILS
Jan 1, 2020
2.42 ILS
Jan 1, 2021
-5.65 ILS
Jan 1, 2022
0.71 ILS
The InterCure Net Debt/FCF history
YEARNet Debt/FCFYoY
0.71-112.57%
-5.65-333.07%
2.42+819.40%
0.26-104.56%
-5.77+976.52%
-0.54-178.43%
0.68-14.84%
0.80—
Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

Net Debt to Free Cash Flow Ratio of InterCure is 0.71 in 2022.

Net Debt to Free Cash Flow Ratio of InterCure changed from -5.65 to 0.71, representing a -112.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio InterCure since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's InterCure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — InterCure

All Key Metrics — InterCure